Introduction
It's one thing to speculate on takeovers. It's another to have a takeover merely as a kicker, with a strong company and a reasonably valued stock. It's yet another when the stock is a blue chip growth stock with a below average P/E. It's even better when the dividend yield is above average for the DJIA (NYSEARCA:DIA). It's even better when sales and earnings are growing. It's better yet when the stock is well off its highs, but moving up, and the company has just increased guidance for this year.
What's this paragon of a stock?
Bristol-Myers Squibb (NYSE:BMY).
